About Us

Company Positioning

Apollomics Biotech (Changzhou) Co., Ltd. focuses on the development and production of stable isotope internal standards and peptide synthesis solutions, providing high-quality custom services for life science research, clinical testing, and biopharmaceutical development.

Product Portfolio

Our core product portfolio includes stable isotope-labeled compounds and peptide products. In the stable isotope field, we provide 13C, 15N, and deuterium-labeled standards as well as custom internal standards for mass spectrometry, metabolism research, and bioanalytical testing.

In the peptide field, we cover research peptides, functional peptides, and structurally modified peptides, including cosmetic peptides, antimicrobial peptides, drug-related peptides, and research-use peptides. We also support peptide synthesis and custom services for complex structures and multiple modification types.

Technical Capabilities

Based on peptide chemistry and computer-aided design capabilities, we have introduced AI-assisted peptide design technologies to optimize and screen peptide sequences according to target function, structural constraints, and sequence features, improving design efficiency and synthesis success rate.

These capabilities can be applied to peptide sequence optimization, stability improvement, cyclic peptide structure design, and modification site selection. By combining experimental synthesis with computational design, we provide integrated solutions from sequence design to synthesis, forming a coordinated technical system covering stable isotope internal standards, peptide synthesis and customization, and AI-assisted peptide design.